| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BioSyent Inc (V: RX)
RX Technical Analysis
5
| As on 27th Dec 2024 RX STOCK Price closed @ 11.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.32 & Strong Buy for SHORT-TERM with Stoploss of 7.70 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RXSTOCK Price
| Open | 11.72 | Change | Price | % |
| High | 11.72 | 1 Day | 0.05 | 0.43 |
| Low | 11.60 | 1 Week | -0.38 | -3.17 |
| Close | 11.60 | 1 Month | 0.45 | 4.04 |
| Volume | 314 | 1 Year | 4.11 | 54.87 |
| 52 Week High 11.98 | 52 Week Low 7.03 | ||||
V Canada Most Active Stocks
| SML | 1435.70 | 0.53% |
| NU | 10.36 | -26.32% |
| QNC | 1.18 | 78.79% |
| ONE | 0.47 | 46.88% |
| VXTR | 0.05 | 0.00% |
| LITH | 0.82 | 3.80% |
| GXU | 0.04 | 0.00% |
| ICM | 0.01 | 0.00% |
| THRM | 0.03 | % |
| BSR | 0.30 | 0.00% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
| RX Daily Charts |
RX Intraday Charts |
Whats New @ Bazaartrend |
RX Free Analysis |
|
|
RX Important Levels Intraday
| RESISTANCE | 11.83 |
| RESISTANCE | 11.76 |
| RESISTANCE | 11.71 |
| RESISTANCE | 11.67 |
| SUPPORT | 11.53 |
| SUPPORT | 11.49 |
| SUPPORT | 11.44 |
| SUPPORT | 11.37 |
RX Forecast December 2024
| 4th UP Forecast | 12.81 |
| 3rd UP Forecast | 12.42 |
| 2nd UP Forecast | 12.18 |
| 1st UP Forecast | 11.94 |
| 1st DOWN Forecast | 11.26 |
| 2nd DOWN Forecast | 11.02 |
| 3rd DOWN Forecast | 10.78 |
| 4th DOWN Forecast | 10.39 |
RX Weekly Forecast
| 4th UP Forecast | 12.54 |
| 3rd UP Forecast | 12.24 |
| 2nd UP Forecast | 12.05 |
| 1st UP Forecast | 11.87 |
| 1st DOWN Forecast | 11.33 |
| 2nd DOWN Forecast | 11.15 |
| 3rd DOWN Forecast | 10.96 |
| 4th DOWN Forecast | 10.66 |
RX Forecast2024
| 4th UP Forecast | 20.7 |
| 3rd UP Forecast | 17.78 |
| 2nd UP Forecast | 15.98 |
| 1st UP Forecast | 14.17 |
| 1st DOWN Forecast | 9.03 |
| 2nd DOWN Forecast | 7.22 |
| 3rd DOWN Forecast | 5.42 |
| 4th DOWN Forecast | 2.5 |
BioSyent Inc ( V Canada Symbol : RX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RX Business Profile
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository for the healing of the anus and rectum; and Cysview, an adjunct to white-light cystoscopy for the detection and management of non-muscle invasive papillary bladder cancer. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, Canada. Address: 2476 Argentia Road, Mississauga, ON, Canada, L5N 6M1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service